Thursday, October 09, 2025 11:15:54 AM
Dr. Linda Liau has confirmed was/is DCVax-L
This is where we get conflicting information, back in 2020 Dr. Prins told me that the vaccine was not DCVax. Danish Dud also received confirmation (I believe from LL) that the vaccine was nearly identical to DCVax but definitively was not DCVax.
This remains muddled until either Dr. provides additional information.
Prins, Robert
Jan 27, 2020, 5:24?PM
This trial has nothing to do with DC-Vax or Northwest Biotherapeutics. We have always had our own IND with the FDA for this vaccine, and we are now combining it with Merck’s PD-1 antibody, pembrolizumab.
Sincerely,
Rob Prins
This is where we get conflicting information, back in 2020 Dr. Prins told me that the vaccine was not DCVax. Danish Dud also received confirmation (I believe from LL) that the vaccine was nearly identical to DCVax but definitively was not DCVax.
This remains muddled until either Dr. provides additional information.
Prins, Robert
Jan 27, 2020, 5:24?PM
This trial has nothing to do with DC-Vax or Northwest Biotherapeutics. We have always had our own IND with the FDA for this vaccine, and we are now combining it with Merck’s PD-1 antibody, pembrolizumab.
Sincerely,
Rob Prins
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
